HC Surgical Specialist profits up 38% to $1.21m in Q1

New acquisitions from the previous financial year brought growth.

SGX-listed HC Surgical Specialists' profits soared 38% to $1.21m in Q1 FY2019-20 ending August, an announcement revealed. Revenue likewise jumped 27.9% to $4.92m over the same period.

The growth in revenue was partly attributed to contributions from new acquisitions during the previous financial year, which include the Jason Lim Endoscopy and Surgery (JLES) and the Medical Services @ Tampines, where an additional 50% equity interest was acquired in September 2018. Existing subsidiaries also recorded increases in income.

Other income increased mainly due to dividend income from investment in financial assets at fair value through profit or loss (“FVTPL”) of $253,000.

The company has expressed plans to expand in Vietnam through Heliconia's network.

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia